Acetaminophen and Acetaminophen-Opioid Combination Prescribing Trends Among Hospitalized Children, Adolescents, and

Insights

Acetaminophen (APAP) use remained stable in US children with cancer, but APAP-opioid combination prescriptions decreased nationally, with regional variations. Further research is needed to assess APAP exposure and liver health in this population.

Area of Science:

  • Pediatric Oncology
  • Pharmacology
  • Public Health

Background:

  • Acetaminophen (APAP) is a common analgesic and antipyretic in children, including those with cancer in the United States (US).
  • Previous studies evaluated US Food & Drug Administration (FDA) guidance on APAP prescribing in healthy children and adults, but patterns in pediatric cancer patients were unknown.
  • Children with cancer face heightened risks of liver injury, making APAP use patterns critical to understand.

Purpose of the Study:

  • To examine the recent trends in acetaminophen (APAP) prescribing among children with cancer in the United States.
  • To analyze the evolution of APAP and APAP-opioid combination use in this vulnerable population.
  • To provide insights into pain management strategies and analgesic exposure in pediatric cancer patients.

Main Methods:

  • A retrospective, multi-center analysis of APAP prescribing data from the Pediatric Health Information System (PHIS) database.
  • Inclusion criteria: children aged 0-26 years with a cancer diagnosis (ICD codes) receiving chemotherapy.
  • Assessment of APAP and APAP-opioid combination prescribing rates at national, regional, and hospital levels using the Mann-Kendall test.

Main Results:

  • Data from 2004-2021 included 388,364 inpatient encounters for 50,779 unique patients; 87.3% received APAP.
  • APAP-opioid combination use was infrequent but more likely among patients receiving APAP (13.4%).
  • National APAP use was stable; regional APAP use increased in the Northeast. APAP-opioid combination use decreased nationally, with consistently elevated use in the South before 2014.

Conclusions:

  • Acetaminophen (APAP) prescribing trends in children with cancer show national stability in APAP use but a decline in APAP-opioid combinations, albeit with regional differences.
  • These findings are crucial for clinicians to evaluate evolving pain management strategies and analgesic exposure in pediatric cancer patients.
  • Further research is warranted to assess the impact of APAP exposure on liver health in children undergoing cancer treatment.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
192
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
670
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
147
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
405
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K